Our study showed that GLS1 downregulation in MCF‐7 cells did not effectively impede proliferation, whereas GLS1 knockout significantly inhibited proliferation and clone formation in various cancer cells, demonstrating CRISPR technology's superiority in studying metabolic enzyme functionality. This evidence concerns the gene GLS and cancer.